NCT03203265 is a NA clinical trial of Group A: Offline HTC in HIV/AIDS, sponsored by Thai Red Cross AIDS Research Centre.

Who is sponsoring NCT03203265?

NCT03203265 is sponsored by Thai Red Cross AIDS Research Centre.

What drugs are being tested in NCT03203265?

Interventions in NCT03203265: Group A: Offline HTC, Group B1: Offline HIV testing and post-test counseling, Group B2: Online HIV testing and post-test counseling.

Is NCT03203265 still recruiting?

NCT03203265 is currently completed. Last updated 25 November 2024.

Last reviewed 2024-11-25 · How we verify

NCT03203265

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Innovative Strategy to Offer Online Test and Treat for Thai MSM/TG

Completed NA Last updated 25 November 2024

What this trial tests

NA trial testing Group A: Offline HTC in HIV/AIDS in 600 participants. Completed in 1 July 2021.

Timeline

6 April 2015

Primary endpoint
1 June 2021

1 July 2021

Quick facts

Lead sponsor	Thai Red Cross AIDS Research Centre
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	single
Primary purpose	screening
Enrollment	600
Start date	6 April 2015
Primary completion	1 June 2021
Estimated completion	1 July 2021
Sites	1 location across Thailand

Drugs / interventions tested

Group A: Offline HTC
Group B1: Offline HIV testing and post-test counseling
Group B2: Online HIV testing and post-test counseling

Conditions studied

HIV/AIDS — all drugs for HIV/AIDS →

Sponsor

Thai Red Cross AIDS Research Centre — full company profile →

Who can join

18 and older, male only, with HIV/AIDS. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will ask Thai MSM and transgender women (TG) participants to self-select to participate in one of the 3 different study groups which provide various degrees of integrated online interventions and offline interventions for the Recruit-Test-Treat-Retain for HIV prevention and care among 3 groups (A, B1 and B2). All participants will be followed up either offline or online for 12 months. HIV-negative participants will be scheduled for repeat HTC at months 6 and 12. HIV-positive participants will be scheduled either offline or online to review their treatment history at months 6 and 12. HIV-negative participants in Group B1 and B2 can choose again at months 6 and 12 to switch from the online to offline, and vice versa, at the HIV testing/post-test counseling step and the referral to HIV treatment step

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

What would you choose: Online or Offline or Mixed services? Feasibility of online HIV counselling and testing among Thai men who have sex with men and transgender women and factors associated with service uptake.
Phanuphak N, Anand T, Jantarapakde J, Nitpolprasert C, et al · · 2018 · cited 48× · PMID 30033644 · DOI 10.1002/jia2.25118
Linkages to HIV confirmatory testing and antiretroviral therapy after online, supervised, HIV self-testing among Thai men who have sex with men and transgender women.
Phanuphak N, Jantarapakde J, Himmad L, Sungsing T, et al · · 2020 · cited 35× · PMID 31960589 · DOI 10.1002/jia2.25448

Verify or expand the search:

Other recruiting trials for HIV/AIDS

Currently open trials in the same condition.

NCT06741618 — MyPEEPS Mobile Plus: A Multi-Level HIV Prevention Intervention for Young MSM · NA · recruiting
NCT07298785 — Peer-led Dynamic Choice HIV Prevention for Women: The Peer-led DCP Pilot Study · NA · recruiting
NCT07072481 — Sustaining Innovative Tools to Expand Youth-Friendly HIV Self-Testing · NA · recruiting
NCT07064785 — Video-Intervention to Inspire Treatment Adherence for Life for Adolescents · NA · recruiting
NCT07074899 — Evaluation of a Multi-Component Intervention to Support HIV Testing and Linkage to Services Among MSM in Peru · NA · active not recruiting

Other Thai Red Cross AIDS Research Centre trials

Trials by the same sponsor.

NCT04590417 — Assessment of Drug-drug Interactions Between Feminizing Hormone Therapy and Emtricitabine/Tenofovir Alafenamide Concomit · NA · active not recruiting
NCT04593680 — Assessment of Drug-drug Interactions Between Masculinizing Hormone Therapy and Antiretroviral Agents Concomitantly for P · NA · active not recruiting
NCT05323695 — Implementation of a Depression Screening Intervention at a Transgender Health Clinic in Thailand · NA · completed
NCT04505501 — Reducing HIV Persistence in Lymph Nodes by Interleukin-15 (IL-15) Receptor Super-agonist (N-803) in Acute HIV Infection · Phase 2 · active not recruiting
NCT04383769 — Differentiated Service Delivery for Antiretroviral Therapy · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03203265 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Thai Red Cross AIDS Research Centre
Last refreshed: 25 November 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03203265.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing